2207 90B STREET SW, EDMONTON, A0
Reaffirm Recommendation to Shareholders: REJECT Curaleaf's Revised Hostile Bid; Preserve Opportunities for Future Upside
Completes Major Expansion of European EU-GMP Manufacturing Facility, More Than Doubling Expected Annual Flower Output
Urges Shareholders to Take No Action to Revised Hostile Bid as Formal Review Underway
Reports Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 for October 2026
Files Application with Alberta Securities Commission to Protect Company Shareholders Having Identified Several Deficiencies in Hostile Bid Disclosure
Aurora Cannabis Updates on Safari Flower Acquisition and European Growth
Refutes Latest Attempt To Distract Shareholders From The Facts
Appoints Seasoned Biopharmaceutical Executive to Lead Commercial Acceleration of Global Medical Cannabis Business
Annual Report of Foreign Private Issuer Pursuant to Section 13(a) or 15(d)
Amended Annual Report of Foreign Private Issuer Pursuant to Section 13(a) or 15(d)
Prospectus Filed Pursuant to Rule 425
Schedule 14D-1F - Tender Offer
Registration Statement for Securities to be Offered to Employees
Certificate
SEC Form 25 - Delisting Notification
Registration of Securities
Effectiveness Notice
No filings found
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report
Appointment of Agent for Service of Process by Foreign Banks and Foreign Insurance Companies